LinkedInยทFriday, 14 August 2026ยท12d ago
๐ช๐ฒ๐น๐ฐ๐ผ๐บ๐ฒ ๐๐ผ ๐๐ต๐ฒ ๐๐ถ๐ผ๐๐ถ๐๐ฎ๐ฟ๐ฑ ๐๐ฒ๐ฎ๐บ, ๐ฆ๐๐ฟ๐๐ฎ!๐ฆ๐งฌ Weโre excited to welcome Surya Koturan, PhD to BioLizard, whereโฆ
Biolizard
9,045 followers
๐ช๐ฒ๐น๐ฐ๐ผ๐บ๐ฒ ๐๐ผ ๐๐ต๐ฒ ๐๐ถ๐ผ๐๐ถ๐๐ฎ๐ฟ๐ฑ ๐๐ฒ๐ฎ๐บ, ๐ฆ๐๐ฟ๐๐ฎ!๐ฆ๐งฌ
Weโre excited to welcome Surya Koturan, PhD to BioLizard, where sheโll join our bioinformatics team to support our clients with pre-clinical translational research.
Surya brings a unique perspective at the interface of computational and experimental biology, with experience spanning bulk, single-cell, and spatial transcriptomics. Her work focuses on using multi-modal data to uncover mechanisms of immune dysfunction and cellular senescence, and translating those insights into hypotheses that can guide drug development.
Weโre looking forward to seeing her expertise in immunology, spatial biology, and translational research contribute to exciting projects and help turn complex data into meaningful decisions.
Weโre very happy to have you with us. ๐
โฅ 122๐ฌ 4
View on LinkedIn Cross-referenced
Related on the wire
Why we donโt celebrate ๐ฆ๐ช๐๐๐ ๐ฌ๐๐ฃ๐จ... In many tech circles, the biggest applause goes to the fastest team. The overnight prototype.โฆ
Looking forward to a morning of great conversations, practical insights, and new connections around the power of omics data and biology onโฆ
Fast code is cheap. But fixing broken data architecture during a clinical trial? Incredibly expensive. It's tempting to jump onto the hypeโฆ
Whatโs worse than a software bug? A bug that silently changes your scientific results. The ๐ซ๐๐๐ ๐๐ค๐๐๐ฃ๐ trend promisesโฆ
๐ ๐๐ฎ๐ฃ๐ฉ๐๐๐ฉ๐๐ ๐๐๐๐ก๐ฉ๐ ๐๐๐ฉ๐ ๐ฅ๐ง๐ค๐ข๐๐จ๐๐จ ๐ฅ๐ง๐๐ซ๐๐๐ฎ, ๐๐ช๐ฉ ๐๐ค๐๐จ ๐๐ฉ ๐๐๐ก๐๐ซ๐๐ง? Synthetic datasets areโฆ
Think AI-generated ๐ซ๐๐๐ ๐๐ค๐๐ will survive an FDA or EMA audit? Think again. In pharma and biotech, ๐๐ฉ ๐ฌ๐ค๐ง๐ ๐จ ๐ค๐ฃ ๐ข๐ฎโฆ